• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者自述未使用一级预防他汀类药物治疗的原因。

Patient-Reported Reasons for Not Using Primary Prevention Statin Therapy.

作者信息

DeWitt Cassandra M, Ponce Robert B, Bry Hayley, Wali Soma, Sedlander Erica, Ladapo Joseph A

机构信息

Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA.

College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.

出版信息

J Clin Med. 2020 Oct 18;9(10):3337. doi: 10.3390/jcm9103337.

DOI:10.3390/jcm9103337
PMID:33080939
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7603153/
Abstract

Almost half of patients who meet American College of Cardiology/American Heart Association (ACC/AHA) criteria for statin therapy are untreated. We aimed to evaluate patient-reported reasons for not using guideline-recommended statin therapy in a public healthcare system. Achieving this goal is key to addressing gaps in care and reducing preventable cardiovascular morbidity. We surveyed patients who met 2013 ACC/AHA guidelines for statin therapy but were not using statins. The survey probed domains of patient knowledge regarding cardiovascular health and benefits of statins, barriers to use, physician trust, and interest in cardiovascular care. Among 71 patients eligible for guideline-recommended statin therapy but not currently taking statins, 49 (69%) had a high school education or lower, 41 (58%) reported that they were unaware they should be prescribed a statin and 49 (69%) were unaware of the benefits of statins. Almost all patients, 70 (99%), reported caring about their cardiovascular health, 61 (86%) reported that they had a high level of trust in their physician, and 51 (72%) reported a willingness to follow their physician's advice. Despite interest in cardiovascular health, awareness of benefits of statin therapy was low and knowledge of recommended statin therapy was low. Increasing patients' awareness of their eligibility through systematic testing and linkage to statin therapy, along with education, may increase statin use among patients recommended for therapy.

摘要

几乎一半符合美国心脏病学会/美国心脏协会(ACC/AHA)他汀类药物治疗标准的患者未接受治疗。我们旨在评估在公共医疗系统中患者报告的未使用指南推荐的他汀类药物治疗的原因。实现这一目标是解决护理差距和降低可预防心血管疾病发病率的关键。我们对符合2013年ACC/AHA他汀类药物治疗指南但未使用他汀类药物的患者进行了调查。该调查探讨了患者在心血管健康和他汀类药物益处方面的知识领域、使用障碍、对医生的信任以及对心血管护理的兴趣。在71名符合指南推荐的他汀类药物治疗条件但目前未服用他汀类药物的患者中,49名(69%)接受过高中或以下教育,41名(58%)报告称他们不知道自己应该服用他汀类药物,49名(69%)不知道他汀类药物的益处。几乎所有患者,70名(99%),报告关心自己的心血管健康,61名(86%)报告对自己的医生高度信任,51名(72%)报告愿意听从医生的建议。尽管对心血管健康感兴趣,但他汀类药物治疗益处的知晓率较低,推荐的他汀类药物治疗知识也较少。通过系统检测和与他汀类药物治疗的联系以及教育来提高患者对自身适用情况的认识,可能会增加推荐治疗患者中他汀类药物的使用。

相似文献

1
Patient-Reported Reasons for Not Using Primary Prevention Statin Therapy.患者自述未使用一级预防他汀类药物治疗的原因。
J Clin Med. 2020 Oct 18;9(10):3337. doi: 10.3390/jcm9103337.
2
American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).美国心脏病学会/美国心脏协会(ACC/AHA)降低动脉粥样硬化性心血管疾病风险的胆固醇治疗I类指南:基于西班牙裔社区健康研究/拉丁裔研究(HCHS/SOL)结果对美国西班牙裔/拉丁裔的影响
J Am Heart Assoc. 2017 May 11;6(5):e005045. doi: 10.1161/JAHA.116.005045.
3
Comparison of Recommended Eligibility for Primary Prevention Statin Therapy Based on the US Preventive Services Task Force Recommendations vs the ACC/AHA Guidelines.基于美国预防服务工作组建议与美国心脏病学会/美国心脏协会指南的一级预防他汀类药物治疗推荐资格比较。
JAMA. 2017 Apr 18;317(15):1563-1567. doi: 10.1001/jama.2017.3416.
4
Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Examination Survey.根据2022年美国预防服务工作组(USPSTF)建议和2018年美国心脏协会(AHA)/美国心脏病学会(ACC)/多学会指南建议,比较他汀类药物用于一级预防的适用情况:来自美国国家健康与营养检查调查。
Prog Cardiovasc Dis. 2022 Nov-Dec;75:78-82. doi: 10.1016/j.pcad.2022.08.007. Epub 2022 Aug 28.
5
Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.美国心脏病学会/美国心脏协会(ACC/AHA)胆固醇指南对几种美国社区卫生中心网络中糖尿病患者心血管疾病预防中他汀类药物未充分利用的影响。
J Am Heart Assoc. 2017 Jul 3;6(7):e005627. doi: 10.1161/JAHA.117.005627.
6
Cardiovascular Risk and Statin Eligibility in Primary Prevention: A Comparison between the Brazilian and the AHA/ACC Guidelines.一级预防中的心血管风险与他汀类药物适用标准:巴西指南与美国心脏协会/美国心脏病学会指南的比较
Arq Bras Cardiol. 2020 Sep;115(3):440-449. doi: 10.36660/abc.20190519.
7
Race and Socioeconomic Differences Associated With Changes in Statin Eligibility Under the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.2013年美国心脏病学会/美国心脏协会胆固醇指南下他汀类药物适用标准变化所涉及的种族和社会经济差异
Circ Cardiovasc Qual Outcomes. 2017 Sep;10(9). doi: 10.1161/CIRCOUTCOMES.117.003764.
8
Comparison of ACC/AHA and ESC Guideline Recommendations Following Trial Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: Results From the Population-Based Rotterdam Study.比较 ACC/AHA 和 ESC 指南建议,基于临床试验证据,在心血管疾病一级预防中使用他汀类药物:来自基于人群的鹿特丹研究的结果。
JAMA Cardiol. 2016 Sep 1;1(6):708-13. doi: 10.1001/jamacardio.2016.1577.
9
Comparison of the application of treatment Panel III and American College of Cardiology/American heart Association guidelines for blood cholesterol treatment in Saudi Arabia.沙特阿拉伯治疗小组III与美国心脏病学会/美国心脏协会血液胆固醇治疗指南应用情况的比较。
J Saudi Heart Assoc. 2018 Oct;30(4):349-355. doi: 10.1016/j.jsha.2018.08.003. Epub 2018 Aug 24.
10
Increases in statin eligibility to reduce cardiovascular risk according to the 2013 ACC/AHA cholesterol guidelines in the Africa Middle East region: a sub-analysis of the Africa Middle East Cardiovascular Epidemiological (ACE) study.根据2013年美国心脏病学会/美国心脏协会(ACC/AHA)胆固醇指南,在非洲中东地区提高他汀类药物适用标准以降低心血管风险:非洲中东心血管流行病学(ACE)研究的一项亚组分析
BMC Cardiovasc Disord. 2019 Mar 15;19(1):61. doi: 10.1186/s12872-019-1034-2.

引用本文的文献

1
Cardiovascular magnetic resonance imaging markers of ageing: a multi-centre, cross-sectional cohort study.衰老的心血管磁共振成像标志物:一项多中心横断面队列研究。
Eur Heart J Open. 2025 May 2;5(3):oeaf032. doi: 10.1093/ehjopen/oeaf032. eCollection 2025 May.
2
Inequities in atherosclerotic cardiovascular disease prevention.动脉粥样硬化性心血管疾病预防中的不平等现象。
Prog Cardiovasc Dis. 2024 May-Jun;84:43-50. doi: 10.1016/j.pcad.2024.05.002. Epub 2024 May 9.
3
Statin Use and Eligibility for Primary Prevention of Atherosclerotic Cardiovascular Disease Among Adults at Borderline or Intermediate Risk in the United States.美国边缘或中度风险成年人中他汀类药物的使用与动脉粥样硬化性心血管疾病一级预防的适用性
J Am Heart Assoc. 2023 Apr 18;12(8):e029263. doi: 10.1161/JAHA.122.029263. Epub 2023 Apr 7.

本文引用的文献

1
Patient-Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry.患者拒绝或停止他汀类药物治疗的原因报告:来自 PALM 注册研究的见解。
J Am Heart Assoc. 2019 Apr 2;8(7):e011765. doi: 10.1161/JAHA.118.011765.
2
Association of Primary Care Providers' Beliefs of Statins for Primary Prevention and Statin Prescription.初级保健提供者对他汀类药物一级预防和他汀类药物处方的信念的关联。
J Am Heart Assoc. 2019 Feb 5;8(3):e010241. doi: 10.1161/JAHA.118.010241.
3
Patient factors that affect trust in physicians: a cross-sectional study.影响患者对医生信任的因素:一项横断面研究。
BMC Fam Pract. 2018 Nov 29;19(1):187. doi: 10.1186/s12875-018-0875-6.
4
Disparities in the Quality of Cardiovascular Care Between HIV-Infected Versus HIV-Uninfected Adults in the United States: A Cross-Sectional Study.美国感染 HIV 与未感染 HIV 成人之间心血管保健质量的差异:一项横断面研究。
J Am Heart Assoc. 2017 Nov 14;6(11):e007107. doi: 10.1161/JAHA.117.007107.
5
Underuse of Prevention and Lifestyle Counseling in Patients With Peripheral Artery Disease.外周动脉疾病患者预防和生活方式咨询的利用不足
J Am Coll Cardiol. 2017 May 9;69(18):2293-2300. doi: 10.1016/j.jacc.2017.02.064.
6
Association of Patient Beliefs and Preferences With Subsequent Testing After Initial Evaluation for Ischemic Heart Disease.缺血性心脏病初始评估后患者信念和偏好与后续检查的关联。
JACC Cardiovasc Imaging. 2017 Sep;10(9):1076-1078. doi: 10.1016/j.jcmg.2016.09.015. Epub 2016 Dec 21.
7
National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey.2002 年至 2013 年美国成年人群体中他汀类药物的使用和支出的国家趋势:来自医疗支出调查的见解。
JAMA Cardiol. 2017 Jan 1;2(1):56-65. doi: 10.1001/jamacardio.2016.4700.
8
A qualitative study to understand guideline-discordant use of imaging to stage incident prostate cancer.一项旨在了解对初发前列腺癌进行分期时影像检查指南不相符使用情况的定性研究。
Implement Sci. 2016 Sep 2;11(1):118. doi: 10.1186/s13012-016-0484-5.
9
A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality.低密度脂蛋白胆固醇、治疗策略及其对心血管疾病发病率和死亡率影响的综述。
J Clin Lipidol. 2016 May-Jun;10(3):472-89. doi: 10.1016/j.jacl.2015.11.010. Epub 2015 Nov 25.
10
Prevalence of Cholesterol Treatment Eligibility and Medication Use Among Adults--United States, 2005-2012.胆固醇治疗适宜性和药物使用在成年人中的流行率——美国,2005-2012 年。
MMWR Morb Mortal Wkly Rep. 2015 Dec 4;64(47):1305-11. doi: 10.15585/mmwr.mm6447a1.